Latest Content
June 10, 2025
Telehealth revolutionizes neurobehavioral reach for underserved children in need
Millions of children live in "neuropsychology deserts" with limited access to expert evaluations. Discover how telehealth is transforming pediatric neuropsychology, breaking down barriers of distance and enabling effective treatment. In this compelling Q&A, Lana Harder, Ph.D., Pediatric Neuropsychologist at Children’s Health, shares how virtual assessments are proving just as effective as in-person visits.
June 6, 2025
Case study: siRNA therapy enables kidney-only transplant in child with rare PH1
Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder that causes excess oxalate, leading to kidney failure and systemic damage. While liver transplant is the only cure, FDA-approved therapies are making kidney-only transplants a viable option—a groundbreaking case study shows how this is possible.
June 5, 2025
Mask-free treatment improves sleep for children with Down syndrome and OSA
Children’s Health is among the few pediatric medical centers in the U.S. offering Inspire therapy, an innovative surgical solution that can help patients with Down syndrome and obstructive sleep apnea (OSA) sleep better. The device stimulates the hypoglossal nerve to keep the tongue pushed forward and the airway open during sleep.
June 4, 2025
GLP-1RAs show promise in addressing pediatric obesity and MASLD
As pediatric obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) rise, Children’s Health is pioneering the use of GLP-1 receptor agonists in adolescents. Backed by a new clinical algorithm, these therapies offer hope where lifestyle changes alone fall short–delivering targeted care for patients most at risk.
June 3, 2025
Pioneering 3-region perfusion technique during Norwood improves survival rate
Children’s Health Heart Center is one of the few in the nation using a groundbreaking three-region perfusion technique during the Norwood procedure. This approach maintains continuous blood flow to vital organs, reduces surgical risks and speeds recovery times for children with congenital heart defects.
June 2, 2025
First-in-kind study validates safety of thalamic sampling during SEEG in Children with DRE
New study at Children’s Health confirms the safety of sampling thalamic nuclei during SEEG in pediatric patients with drug-resistant epilepsy (DRE). The findings revealed that accurate thalamic mapping can improve neuromodulation targeting. This approach may significantly enhance outcomes for children who aren’t candidates for epilepsy surgery.
